Press Releases

Aug 12, 2019
Axcella Health Reports Second Quarter 2019 Financial Results and Provides Company Update
Aug 07, 2019
Axcella to Present at the Wedbush PacGrow Healthcare Conference
Jul 31, 2019
Axcella Announces Publication of Data Describing Attenuation of Muscle Atrophy with AXA2678 in Short-Term Muscle Disuse Study
Jun 20, 2019
Axcella Health Reports First Quarter 2019 Financial Results and Provides Company Update
May 13, 2019
Axcella Health Announces Closing of Initial Public Offering
May 08, 2019
Axcella Health Announces Pricing of Initial Public Offering
Apr 11, 2019
Axcella Presents Late-Breaker Data Demonstrating Lead AXA™ Candidate AXA1665 Impacted Markers Related to Liver Health
Apr 02, 2019
Axcella Announces Patent Issuance for AXA™ Candidate AXA1125 Methods of Use
Mar 27, 2019
Axcella to Present Late-Breaker Data on Lead AXA™ Candidate, AXA1665 at EASL, the International Liver Congress™
Mar 25, 2019
Axcella Appoints Shreeram Aradhye, M.B.B.S., M.D., as Executive Vice President, Chief Development Officer
Displaying 1 - 10 of 13